Back to top
more

UnitedHealth Group (UNH)

(Delayed Data from NYSE)

$492.45 USD

492.45
2,487,657

-0.52 (-0.11%)

Updated May 3, 2024 04:00 PM ET

After-Market: $492.25 -0.20 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 22% (197 out of 252)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.

HCA Healthcare's (HCA) Q4 Earnings Beat on Improved Admissions

by Zacks Equity Research

HCA Healthcare (HCA) expects EPS in the range of $19.70-$21.20 for 2024, the midpoint being 7.6% higher than the 2023 figure.

Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock

by Zacks Equity Research

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

by Zacks Equity Research

Sector ETF report for IHF

Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DIA

Should Vanguard Mega Cap Value ETF (MGV) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for MGV

Should You Invest in the iShares U.S. Healthcare ETF (IYH)?

by Zacks Equity Research

Sector ETF report for IYH

Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?

by Zacks Equity Research

Sector ETF report for XLV

Is Nuveen ESG Large-Cap Value ETF (NULV) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for NULV

Should You Invest in the Vanguard Health Care ETF (VHT)?

by Zacks Equity Research

Sector ETF report for VHT

Wall Street Bulls Look Optimistic About UnitedHealth (UNH): Should You Buy?

by Zacks Equity Research

According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?

by Zacks Equity Research

UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Sweta Killa headshot

UnitedHealth Beats on Q4 Earnings, Shares Slip: ETFs in Focus

by Sweta Killa

The largest U.S. health insurer UnitedHealth Group (UNH) reported better-than-expected fourth-quarter 2023 results but medical costs rose more than expected for the first time in two years.

UnitedHealth (UNH) Stock Declines 3.4% on High Medical Costs

by Zacks Equity Research

As more seniors resume elective procedures, claims rise in UnitedHealth's (UNH) Medicare Advantage business.

UnitedHealth Group (UNH) Q4 Earnings Beat on Membership Growth

by Zacks Equity Research

UnitedHealth Group's (UNH) Q4 results benefit on the back of double-digit revenue growth in its UnitedHealthcare and Optum segments. Management maintains its 2024 adjusted EPS target within $27.50-$28.00.

Earnings Data Deluge

by Zacks Equity Research

Earnings Data Deluge.

Mark Vickery headshot

PPI Moves Lower, Along with Big Banks on Q4 Earnings

by Mark Vickery

Many of today's PPI metrics clearly point to low-growth elements within the wholesale market.

UnitedHealth (UNH) Reports Q4 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

UnitedHealth Group (UNH) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

UnitedHealth (UNH) delivered earnings and revenue surprises of 3.01% and 2.57%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Mark Vickery headshot

Q4 Earnings from Wall Street On Deck: JPMorgan, Citi, BofA and Wells Fargo

by Mark Vickery

We turn our attention to Q4 earnings season, which picks up steam Friday morning before the opening bell.

December CPI Hotter-Than-Expected

by Zacks Equity Research

December CPI Hotter-Than-Expected

Can UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q4 Earnings?

by Zacks Equity Research

UnitedHealth's (UNH) fourth-quarter results are expected to benefit from an increase in UnitedHealthcare's Medicare & Retirement revenues as well as the number of people it served.

Mark Vickery headshot

CPI Warmer than Expected; Jobless Claims Stay Low

by Mark Vickery

Core CPI year over year of +3.9% is the first sub-4% print since May 2021.

Sweta Killa headshot

Will Q4 Earnings Push Dow ETF Higher?

by Sweta Killa

Let's delve deeper into the probable fourth-quarter earnings picture that will likely aid Dow ETF in the coming days.

Wall Street Awaits Key Inflation Data

by Zacks Equity Research

Wall Street Awaits Key Inflation Data